Reaction

Which drugs are most reported with Liquid product physical issue?

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 6,972 reports · 79 co-occurring drugs

As of the last recalculation, Liquid Product Physical Issue appears in 6,972 FAERS reports alongside 79 co-occurring drug terms. The strongest observed disproportionality signal is TESTOSTERONE CYPIONATE (PRR 84.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Testosterone Cypionate	244	84.5	86.8
Somatropin	757	34.4	34.7
Epinephrine	646	32.4	32.7
Adrenalinum	419	32.0	32.3
Guselkumab	236	20.4	20.5
Prednisolone Acetate	44	12.8	12.8
Travoprost	32	11.1	11.1
Testosterone	81	10.5	10.5
Human Insulin	41	9.9	9.9
Insulin Aspart	193	8.9	9.0
Human Immunoglobulin G	61	8.9	8.9
Brinzolamide	24	8.3	8.3
Insulin Glulisine	28	8.2	8.3
Abaloparatide	74	7.6	7.6
Ustekinumab	245	7.4	7.4
Lifitegrast	39	7.2	7.2
Carboxymethylcellulose Sodium	21	6.7	6.7
Insulin Degludec	44	5.6	5.6
Budesonide	104	5.3	5.3
Teduglutide	24	5.3	5.3
Erenumab-Aooe	96	5.3	5.3
Fremanezumab-Vfrm	19	5.0	5.0
Dorzolamide Hydrochloride And Timolol Maleate	13	4.9	4.9
Timolol Maleate	14	4.2	4.2
Timolol	17	4.2	4.2
Methylprednisolone Acetate	11	4.1	4.1
Cannabidiol	30	3.8	3.8
Medroxyprogesterone Acetate	58	3.5	3.5
Lanreotide Acetate	9	3.4	3.4
Oxcarbazepine	37	3.4	3.4
Clobetasol Propionate Ointment Usp, 0.05%	10	2.9	2.9
Clobetasol Propionate	10	2.9	2.9
Cyclosporine	104	2.8	2.8
Tretinoin	7	2.6	2.6
Naltrexone	26	2.5	2.5
Paliperidone Palmitate	27	2.5	2.5
Latanoprost	42	2.5	2.5
Oral Semaglutide	60	2.5	2.5
Estradiol Gel 0.1%	36	2.4	2.4
Estradiol Transdermal	36	2.4	2.4
Anakinra	13	2.3	2.3
Dicyclomine Hydrochloride	11	2.3	2.3
Triamcinolone Acetonide	23	2.2	2.2
Brimonidine Tartrate	13	2.2	2.2
Triamcinolone Acetonide Ointment Usp, 0.05%	17	2.2	2.2
Adalimumab	489	2.1	2.1
Vancomycin Hydrochloride	46	2.1	2.1
Guanfacine	5	1.9	1.9
Clobazam	15	1.8	1.8
Epoprostenol	8	1.8	1.8
Leuprolide Acetate	46	1.8	1.8
Methylphenidate Hydrochloride	35	1.8	1.8
Tobramycin Solution	7	1.7	1.7
Budesonide, Glycopyrrolate, And Formoterol Fumarate	6	1.7	1.7
Tobramycin Sulfate	7	1.7	1.7
Azelastine	10	1.7	1.7
Ofatumumab	17	1.5	1.5
Liraglutide	25	1.5	1.5
Asfotase Alfa	5	1.5	1.5
Bimatoprost	14	1.5	1.5
Insulin Glargine	117	1.4	1.4
Icosapent Ethyl	4	1.4	1.4
Golimumab	40	1.4	1.4
Abatacept	64	1.4	1.4
Brivaracetam	4	1.3	1.3
Omalizumab	36	1.3	1.3
Tobramycin	10	1.2	1.2
Benralizumab	8	1.2	1.2
Nemolizumab-Ilto	5	1.2	1.2
Certolizumab Pegol	43	1.1	1.1
Emicizumab	4	1.0	1.0
Peginterferon Alfa-2A	17	0.9	0.9
Onabotulinumtoxina	24	0.9	0.9
Esketamine Hydrochloride	4	0.7	0.7
Evolocumab	33	0.6	0.6
Bimekizumab	4	0.6	0.6
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	5	0.5	0.5
Minoxidil	7	0.5	0.5
Galcanezumab-Gnlm	4	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.